IndustryPayments
Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

JAMAL A ABUKHALED

Allopathic & Osteopathic Physicians Internal Medicine Nephrology

NPI
1518285451
CMS profile
377977
Location
ROYAL OAK, MI

General Payments · PY2018–2024

$5,752.96

  • Reported across 138 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$1,255.04

49 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

Related groups: Nephrology MI All categories

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,170.05 48
Education $84.99 1

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Alexion Pharmaceuticals, Inc. $279.61 7
Amgen Inc. $266.27 7
Boehringer Ingelheim Pharmaceuticals, Inc. $182.00 13
Acerta Pharma LLC $83.79 3
Otsuka America Pharmaceutical, Inc. $61.01 3
Retrophin, Inc. $57.91 2
Aurinia Pharma U.S., Inc. $52.34 2
NOVARTIS PHARMACEUTICALS CORPORATION $51.50 2
SHIELD THERAPEUTICS INC $50.39 2
Mallinckrodt Hospital Products Inc. $47.40 2
CALLIDITAS THERAPEUTICS US INC. $42.65 2
GlaxoSmithKline, LLC. $38.21 2
Ardelyx, Inc. $25.53 1
Bayer HealthCare Pharmaceuticals Inc. $16.43 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $372.46 3
PY2019 $2,093.25 8
PY2020 $219.61 3
PY2021 $191.11 5
PY2022 $546.65 28
PY2023 $1,074.84 42
PY2024 $1,255.04 49

Payment records · PY2024 (49)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Alexion Pharmaceuticals, Inc. $32.25 01/17/2024 Food and Beverage Undisputed 01/23/2026 1093891660 CMS
Alexion Pharmaceuticals, Inc. $34.34 02/14/2024 Food and Beverage Undisputed 01/23/2026 1093907382 CMS
Alexion Pharmaceuticals, Inc. $32.57 04/11/2024 Food and Beverage Undisputed 01/23/2026 1093987114 CMS
Alexion Pharmaceuticals, Inc. $30.55 04/24/2024 Food and Beverage Undisputed 01/23/2026 1093898757 CMS
Alexion Pharmaceuticals, Inc. $34.53 05/01/2024 Food and Beverage Undisputed 01/23/2026 1094026105 CMS
Alexion Pharmaceuticals, Inc. $84.99 05/02/2024 Education Undisputed 01/23/2026 1093985901 CMS
Alexion Pharmaceuticals, Inc. $30.38 10/23/2024 Food and Beverage Undisputed 01/23/2026 1094049882 CMS
Amgen Inc. $109.38 01/25/2024 Food and Beverage Undisputed 01/23/2026 1117184149 CMS
Amgen Inc. $25.82 05/15/2024 Food and Beverage Undisputed 01/23/2026 1117184151 CMS
Amgen Inc. $15.43 05/30/2024 Food and Beverage Undisputed 01/23/2026 1117184153 CMS
Amgen Inc. $34.77 07/24/2024 Food and Beverage Undisputed 01/23/2026 1117184155 CMS
Amgen Inc. $25.52 10/16/2024 Food and Beverage Undisputed 01/23/2026 1111508917 CMS
Amgen Inc. $29.52 11/21/2024 Food and Beverage Undisputed 01/23/2026 1111508919 CMS
Amgen Inc. $25.83 11/21/2024 Food and Beverage Undisputed 01/23/2026 1111508921 CMS
Ardelyx, Inc. $25.53 01/11/2024 Food and Beverage Undisputed 01/23/2026 1146666731 CMS
AstraZeneca Pharmaceuticals LP $29.55 02/07/2024 Food and Beverage Undisputed 01/23/2026 1104756510 CMS
AstraZeneca Pharmaceuticals LP $22.59 04/04/2024 Food and Beverage Undisputed 01/23/2026 1104630758 CMS
AstraZeneca Pharmaceuticals LP $31.65 09/26/2024 Food and Beverage Undisputed 01/23/2026 1105778866 CMS
Aurinia Pharma U.S., Inc. $25.93 09/14/2024 Food and Beverage Undisputed 01/23/2026 1150674283 CMS
Aurinia Pharma U.S., Inc. $26.41 12/04/2024 Food and Beverage Undisputed 01/23/2026 1150674285 CMS
Bayer Healthcare Pharmaceuticals Inc. $16.43 10/10/2024 Food and Beverage Undisputed 01/23/2026 1086107902 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $9.57 01/25/2024 Food and Beverage Undisputed 01/23/2026 1118040996 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $15.33 02/07/2024 Food and Beverage Undisputed 01/23/2026 1118040974 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $17.31 05/02/2024 Food and Beverage Undisputed 01/23/2026 1118040976 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $5.63 05/15/2024 Food and Beverage Undisputed 01/23/2026 1118040988 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $4.96 05/22/2024 Food and Beverage Undisputed 01/23/2026 1118040986 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $8.28 06/12/2024 Food and Beverage Undisputed 01/23/2026 1118040994 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $22.03 07/17/2024 Food and Beverage Undisputed 01/23/2026 1118040980 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $22.55 07/30/2024 Food and Beverage Undisputed 01/23/2026 1118040982 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $15.13 08/14/2024 Food and Beverage Undisputed 01/23/2026 1118040972 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $7.15 08/29/2024 Food and Beverage Undisputed 01/23/2026 1118040992 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $6.22 10/09/2024 Food and Beverage Undisputed 01/23/2026 1118040990 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $21.08 11/06/2024 Food and Beverage Undisputed 01/23/2026 1118040978 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $26.76 11/20/2024 Food and Beverage Undisputed 01/23/2026 1118040984 CMS
CALLIDITAS THERAPEUTICS US INC. $24.45 06/06/2024 Food and Beverage Undisputed 01/23/2026 1141516503 CMS
CALLIDITAS THERAPEUTICS US INC. $18.20 07/11/2024 Food and Beverage Undisputed 01/23/2026 1141518281 CMS
GlaxoSmithKline, LLC. $17.52 04/18/2024 Food and Beverage Undisputed 01/23/2026 1116640598 CMS
GlaxoSmithKline, LLC. $20.69 06/13/2024 Food and Beverage Undisputed 01/23/2026 1116687269 CMS
Mallinckrodt Hospital Products Inc. $21.17 01/25/2024 Food and Beverage Undisputed 01/23/2026 1145044335 CMS
Mallinckrodt Hospital Products Inc. $26.23 05/23/2024 Food and Beverage Undisputed 01/23/2026 1145044337 CMS
Novartis Pharmaceuticals Corporation $23.31 09/04/2024 Food and Beverage Undisputed 01/23/2026 1086750331 CMS
Novartis Pharmaceuticals Corporation $28.19 12/18/2024 Food and Beverage Undisputed 01/23/2026 1086750341 CMS
Otsuka America Pharmaceutical, Inc. $26.43 01/31/2024 Food and Beverage Undisputed 01/23/2026 1118847708 CMS
Otsuka America Pharmaceutical, Inc. $16.04 04/30/2024 Food and Beverage Undisputed 01/23/2026 1118847710 CMS
Otsuka America Pharmaceutical, Inc. $18.54 12/11/2024 Food and Beverage Undisputed 01/23/2026 1118847712 CMS
SHIELD THERAPEUTICS INC $24.52 08/28/2024 Food and Beverage Undisputed 01/23/2026 1150143950 CMS
SHIELD THERAPEUTICS INC $25.87 10/30/2024 Food and Beverage Undisputed 01/23/2026 1150151788 CMS
Travere Therapeutics, Inc. $29.31 03/06/2024 Food and Beverage Undisputed 01/23/2026 1149908160 CMS
Travere Therapeutics, Inc. $28.60 09/18/2024 Food and Beverage Undisputed 01/23/2026 1149908156 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.